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RESUM 
S'estudia el mecanisme d'increment cellular durant el desenvolupament del pseudoblastema, 
tap cellular que es forma durant el procés de regeneració de ferides en els himdinis. A Hiru- 
do medicinalis, el pseudoblastema esti format per cbllules vasocentrals provinents del teixit 
vasofibrós. La detecció de proliferació cellular per incorporació de BrdU mostra la capacitat 
de dividir-se de les cbllules vasocentrals en espbcimens immadurs. Els espbcimens madurs 
tenen una gran dificultat per incorporar BrdU i no se n'han obtingut resultats. Les observa- 
cions histologiques mostren la importincia de la migració cellular, l'empobriment en 
cbl.lules vasocentrals al teixit vasofibrós en ferides severes i el reempla~ament posterior, pre- 
sumiblement per proliferació cellular, de les cbllules vasocentrals perdudes. 
RESUMEN 
Se estudia el mecanismo de incremento celular durante el desarrollo del pseudoblastema, un 
tapón celular que se forma durante el proceso de regeneración de heridas en 10s hirudineos. 
En Hirudo medicinalis, el pseudoblastema está formado por células vasocentrales provenien- 
tes del tejido vasofibroso. La detección de proliferación celular por incorporación de BrdU 
muestra la capacidad de dividirse de las células vasocentrales en especimenes inmaduros. Los 
especimenes maduros tienen una gran dificultad para incorporar BrdU y no se han obtenido 
resultados. Las observaciones histológicas muestran la importancia de la migración celular, el 
empobrecimiento en células vasocentrales en el tejido vasofibroso en heridas severas y el 
posterior reemplazamiento, presumiblemente por proliferación celular, de las células vaso- 
centrales perdidas. 
ABSTRACT 
How cells are provided during the development of the pseudoblastema, a cell plug formed 
during wound healing in Himdinea, was studied. In Hirudo medicinalis, the pseudoblastema 
is formed by vasocentral cells arising from the vasofibrous tissue. Detection of cell prolifera- 
tion by incorporation of BrdU shows the ability of vasocentral cells to proliferate in immature 
specimens. Mature specimens present great difficulties for incorporating BrdU so no data 
was obtained. Histological observations show the importance of cell migration in the pseudo- 
blastema growth, the impoverishment in vasocentral cells of the vasofibrous tissue in long 
term severe wounds and the replacement, presumably by proliferation, of loose vasocentral 
cell in later stages. 
Key word:Cell proliferation, Hirudo medicinalis, leech, pseudoblastema, vasocentral cell, wound 
healing. 
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INTRODUCTION 
The origin of cellular regeneration is a central matter in wound healing. Two 
cell sources should be considered: cell growth and cell migration. 
During leech wound healing, one of the first events is the formation of a cell 
plug at the wound site. This cell plug, named pseudoblastema, grows progressively 
during the first stages of the wound healing. Cells that clump to form the pseudo- 
blastema are connective cells that migrate hom the so called "vasofibrous tissue", a 
thread-like network of fibrils located mainly in the peridigestive region, consisting 
of pigmented vasofibrous cells surrounding small groups of clear vasocentral cells 
(Huguet and Molinas, 1994). 
Since no data is available concerning cell proliferation in cell plugs in Hirudi- 
nea, our purpose was the study of the mechanisms of the pseudoblastema growth. In 
Polychaeta and Oligochaeta the cell plug formed in the wound site, with no regene- 
rating activity, is later replaced by other cells forming the blastema that show a high 
degree of cell proliferation (Burke, 1974; Chapron, 1964; Douglas, 1970; Jamieson, 
1981). The absence of cell division in the initial cell plug that precedes the blastema 
is reported in Polychaeta (Douglas, 1970). In Hirudinea cell proliferation has been 
detected in the regenerating epidermis of Helobdella stagnalis (Cornec, 1990), but 
not in the cell plug. In previous works (Huguet and Molinas, 1988, 1992, 1994) no 
mitotic figures have been detected in healing tissues of Hirudo medicinalis, even 
following a colchicine treatment (unpublished data). 
Timidine analogs, respectively 3H timidine and 5-bromo 2'deoxiuridine, have 
been widely used to study mitotic activity. However, the incorporation of nucleoti- 
de analogs is apparently difficult in freshwater invertebrates as reported by Baguñi 
et al. (1989) in planarians and Cornec (1990) in the leech Helobdella stagnalis. We 
discuss the usefulness of 5-bromo 2'deoxiuridine in Hirudinea and provide detailed 
descriptions of protocols used. 
MATERIALS AND METHODS 
Living material 
Specimens of Hirudo medicinalis L. from lagoons in Alt Empordi (Girona, 
Spain) and one-month-old specimens kindly provided by Biopharm (U.K.) were 
used. They were acclimatized to laboratory conditions before being used for experi- 
ments. The temperature of the water in the aquariums containing the leeches was 
about 18 "C. In these conditions some adult specimens produced fertile cocoons 
from which young leeches were obtained. 
To perform this work, the animals were anaesthetized with 8 % ethanol for 15 
minutes and disinfected superficially with ethanol. Two different types of wounds 
were performed, incision wounds and N03Ag impregnations. Incisions were made 
on the ventral surface of the leeches, between annuli 65 to 85, affecting epidermal, 
derma1 and muscle layers of the body wall. N03Ag impregnations were made with a 
cotton moistened with a saturated solution of N03Ag applied during two seconds on 
the same body region. Recovery took place in 2% sodium p-toluol sulfocloramide 
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(chlorine) solution to avoid infection. 
Series of N03Ag wounds were performed and the animals were killed 10 min., 4 I 
hours, 24 hours, 48 hours, 6 days, 8 days, 15 days, 30 days, 36 days and 63 days 
post-injury for conventional histological observations. 
The exemplars used in the different proliferation detection tests were: 
- Tests 1 to 5: series of mature exemplars with incision wounds, killed: 8 hours, 
24 hours, 48 hours, 3 days, 4 days, 5 days, 7 days, 10 days, 14 days, 25 days and 60 
days post-injury, for every test. 
- Tests 6 and 7: immature exemplars born in our laboratory, about one month 
old and with a single feed consisting of frog blood, with 5 days incision wounds. 
- Tests 8 and 9: immature exemplars about one month old provided by Biop- 
harm, fed with mammalian blood. In test number 8, incision wounds were made and 
exemplars were killed 48 hours, 3 days, 7 days, 14 days and 25 days post injury. In 
the test number 9, N03Ag treatments were made and exemplars were killed 7 days 
and 14 days post injury. 
In each test, two exemplars for each post-injury period were used. Controls with 
Mus musculus were also tested. 
Methods 
For conventional histological observations, the specimens were fixed in 4 % for- 
maldehyde in phosphate buffer, pH 7.2. Samples were embedded in glycol-met- 
hacrylate (Bonet and Molinas, 1983) and stained with hematoxylin/eosin. 
In the study of cell proliferation two different commercial kits were used: "Cell 
Proliferation RPN-20" (Amersham) and "5-Bromo-2'-deoxy-uridine Labeling and 
Detection Kit I" (Boehringer), both based on the same principle: the incorporation of 
BrdU in newly synthesized DNA and its posterior detection with antibodies. Simul- 
taneously with primary antibody incubation a nuclease digestion of DNA was used 
to allow antibody access. The first kit used a peroxidase labeled secondary antibody 
and in the second one it was fluorescein labeled. 
After anaesthesia, the specimens were injected with dilutions of BrdU (see table 
I) in the Ringer's solution for leeches: NaC1, 115 mM; CaCl,, 1.8 mM; KC1, 4 mM; 
Tris maleate buffer, 10 mM @H 7.4) (Sawyer, 1986). Depending on the size of the 
leech, 0.2-0.4 ml were injected into two different points of the body. Frequently 
during the injection the fluid flows into the gut. In every test, two exemplars were 
injected without BrdU. 
In tests 3 to 9, besides injection, 0.6 mg BrdU / ml was added to the jar water 
(Table I). 
After different periods of BrdU incubation (see table I) the specimens were killed 
with long term anaesthesia, and fixation subsequently took place. Tissues were pro- 
cessed for paraffin or criotom techniques and immunodetection was made (Table I). 
Different strategies were used to optimize the results (Table I). To solve the pro- 
blem of non-incorporation of BrdU, higher concentrations and longer periods of 
BrdU incubation were tested. Incubation with hydrogen peroxide 2 % in methanol 
just after deparaffination and rehidratation was tested in order to reduce endogen 
62 PSEUDOBLASTEMA GROWTH DURING WOUND HEALING ... 
peroxidase activity. To solve troubles with the binding of the primary antibody with 
BrdU, more accurate deparaffination, complementary DNA digestion with ClH 2 N 
for 30 minutes followed by neutralization with borate buffer 0,13 M (PH 8,5), and 
longer periods of antibody incubation were tested. 
RESULTS 
After incision wounds, cells from the vasofibrous tissue migrate to form a com- 
pact plug on the wound surface, the pseudoblastema (Figs. 1,2). In our experimental 
conditions, the first migratory cells are observed 10 minutes post-injury. One hour 
later, cells have reached the wound limit, and 4 hours post-injury, a developed pseu- 
doblastema is present. The pseudoblastema shows a high growth rate unti1 48 hours 
wich subsequently decreases. Finally, between days 10 and 14 post-injury, the pseu- 
doblastema begins to disintegrate and 5 weeks post-injury the disintegration is com- 
plete. 
In NO,Ag treatments, argentic salts penetrate into the body's wall tissues affec- 
ting the epidermis, the dermis and the externa1 layers of the musculature (Fig. 3). 
The wound affects a very large area, about 2-3 X 4-4.5 mm. About hour 24, vaso- 
central cells accumulate just below the impregnated tissues, and later (days 3-5) all 
the impregnated tissue mass splits out, leaving a surface covered by the pseudoblas- 
tema (Fig. 4). After day 15, little growth of the pseudoblastema can be observed, 
although abundant migratory vasocentral cells are found in the pseudoblastema 
vicinity. The pseudoblastema is present during long periods, and disintegration 
begins after 30 days. 
Cell proliferation 
Of all the experiments tested only test number 6 gives positive results in leech 
tissues. Controls with tongue and intestinal tissues of Mus musculus are positive as 
expected. The bacteria usually found in leech nephridia are labeled in all the diffe- 
rent tests as well. Inespecific labeling with primary antibody is observed in vasofi- 
brous cell granules, inclusively without BrdU incubation. 
No BrdU labeling is observed in regenerating tissues or in the neighboring tis- 
sues of adult specimens. In tissues with active proliferation expected, i.e. intestinal 
epithelium or germinal line, no labeling is either observed. 
In an immature specimen, corresponding to test number 6, with an incision 
wound of 5 days, labeling is observed. Labeling is located in intestinal epithelial 
cells, vasofibrous tissue of the intestinal vicinity, pseudoblastema cells, and vaso- 
central cells near the pseudoblastema (Figs. 5 to 8). Nearly all the intestinal epithe- 
lial cells are positive, but no labeling is detected in intestinal caecums (Fig. 5 and 
6). Concerning the vasofibrous tissue, we cannot distinguish whether the labeling is 
in the vasofibrous cells or in the vasocentral cells. The pseudoblastema presents 
labeled cells in the basal zone (Fig. 7). 
The other exemplar of test number 6 died 24 hours before the planned sacrifice 
and subsequent fixation. Although tissues were poorly conserved, labeling can be 
observed in nuclei distributed in the connective tissue. 
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Vasofibrous tissue during the regeneration process 
In the incision wounds, no changes have been observed in the vasofibrous tis- 
sue, but they are clearly detectable in the N0,Ag treatments. Those changes can be 
clearly observed in the vasofibrous tissue located around the nerve cord (Figs. 9 to 
12). 
In the stages previous to tissue splitting, vasocentral cells separate from the 
vasofibrous tissue and migrate to the affected area. Migration becomes progressi- 
vely more important (Fig. 10). A short time after the beginning of migration and 
during the first stages of the regeneration process (4 hours to 6 days), the vasofi- 
brous tissue of the wound vicinity becomes poor in vasocentral cells. Later, betwe- 
en 8 and 36 days, an increment of vasocentral cells in the vasofibrous tissue can be 
observed, even over normal levels, especially around day 15 (Fig. 11). Once the 
pseudoblastema has been disintegrated (63 days), vasofibrous tissue shows a nor- 
mal aspect (Fig. 12). 
DISCUSSION 
During the pseudoblastema evolution, growth can be observed, mainly during 
the first stages. This growth may be only due to migration of vasocentral cells ari- 
sing from the vasofibrous tissue or, besides this mobilization, to proliferation of 
vasocentral cells. 
The proliferation detection experiments are not conclusive. Like other inverte- 
brates (Baguña et al., 1989; Cornec, 1990), Hirudo medicinalis seems to present a 
notable difficulty for incorporating nucleotide analogs. 
We postulate that the maturation level is important in the label incorporation 
process, since only immature specimens with a single feed consisting of frog blood 
do incorporate BrdU. On the other hand, one-month-old specimens fed with mam- 
malian blood do not show any labeling. Even if they are as old as the specimens of 
the anterior group, they exhibit a later maturation level, possibly due to their more 
complete feeding. 
Labeling in the intestinal epithelium may be due to the accessibility of BrdU, 
which usually flows into the gut during injection. The fact that only the vasofibrous 
tissue located near the intestine incorporates BrdU may be due to the same reason. 
The presence of labeled cells in the pseudoblastema does not necessary indicate 
that cells proliferate in the pseudoblasterna. They could be labeled in their original 
tissues (vasofibrous tissue) and subsequently migrate to the wounded area. TWO 
facts point out that, in this specimen, BrdU incorporation took place in the perintes- 
tina1 vasofibrous tissue. First, only the basal zone of the pseudoblastema (where 
presumably migrating cells are added) contains labeled cells, and, second, the pre- 
sence of migrating labeled vasocentral cells near the pseudoblasterna. This does not 
reject the possibility that pseudoblastema cells do proliferate. Experiments allowing 
accessibility of BrdU to the pseudoblastema together with short incubation periods 
may solve this question. 
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Despite the capability of vasocentral cells to proliferate, the continuous affluen- 
ce of vasocentral cells to the pseudoblastema during the pseudoblastema growth 
induces us to think that migration is the principal mechanism of growth. 
After N0,Ag treatments, in which there is a massive and lasting migration, 
vasofibrous tissue becomes severely poor in vasocentral cells. The increment of 
vasocentral cells obsemed in the subsequent stages may be attributed to a putative 
proliferation process occurred to satisfy the claim of vasocentral cells during the 
long regeneration periods. 
In conclusion, besides migration, proliferation may occur during the evolution 
process of the pseudoblastema. Despite the fact that our experiments are not conclu- 
sive, they show that vasocentral cells have proliferative ability during wound hea- 
ling at least in immature exemplars, and probably, as NOPg wound healing obser- 
vations indicate, in mature exemplars as well. 
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Fig. 1. Cluster of vasocentral cells surrounded by vasofibrous cell p:ojections. Hema- 
toxylin/eosin stained. GV, group of vasocentral cells; V, vasofibrous cell. Scale bar, 10 
Pm. 
Fig. 2. Incision wound about 4 h post-injury. Vasocentral cells have reached the 
wound edges and the pseudoblastema is formed. Hematoxylin/eosin stained. CT, connecti- 
ve tissue; M, musculature; MC, migratory vasocentral cells; P, pseudoblastema. Scale bar, 
100 pm. 
Fig. 3. N0,Ag treatment 24 h post-injury. Argentic precipitates are seen in the body 
wall and vasocentral cells accumulate just below the impregnated zone (arrow). Hema- 
toxylin/eosin stained. AG, argentic precipitates; NC, nerve cord. VC, vasocentral cell; V, 
vasofobrous tissue. Scale bar, 100 pm. 
Fig. 4.6 days post-injury the impregnated tissues had been spliced and the pseudoblas- 
tema recovers the externa1 surface. Hematoxylin/eosin stained. P, pseudoblastema; V, 
vasofibrous tissue. Scale bar, 100 ym. 
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Figs. 5 to 8. Specimen with a incision wound 5 days post-injury incubated with BrdU. 
The presence of labeled nuclei h detected by immunohistochernistry with the presence of a 
brom precipitate. 
Fig. 5. Peridigestive ara. Nuclei of intestinal epithelium (arrow) and va so^ tis- 
sue of the intestinal vicinity (double arrow) are labeled. Hernatoxylin/eosin staincd. I, 
intestine; IC, intestinal caecum. Scale bar, 100 pm. 
Fig. 6. Detail of the previous image. Hernatoxylin,eosin stained. IE, intestinal epithe- 
liurn; V, vasofibrous tissue. W e  bar, 100pm. 
Fig. 7. Pseudoblastema 5 days post-injury. Some pseudoblasterna cells are labeled 
(arrow), rnainly in the basal zone. Iu the upper zone of the pseudoblastema no labeling is 
observed (double m w ) .  Some labeled vasocentral cells are in the pseudoblastema vici- 
nity (arrow point). Hemaioxylin/tosin stained. Scale bar, 100 pm. 
Fig. 8. Pseudoblastema 5 days post-injury. Pseudoblastema labeled cells (armw) and 
Iabeled vasocentral cells in the pseudoblastema vicinity (anow point). Hematoxylideosin 
stained. Scale bar, 100 pm. 
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Figs. 9 to 12. Vasofibrous tissue located around the nerve cord in different specimens 
~ u ~ & N o , A ~  treatments. 
Fig. 9. Uninjured exemplar with normal vasofibrous tissue. Hematoxylin/eosin stai- 
ned. NC, nerve cord; V, vasofibrous tissue. Scale bar, 100 pm. 
Fig. 10. 4 h post-injury. Vasocentral cells detach from the vasofibrous tissue and 
initiate migration (arrow). Vasofibrous tissue appears vacuolated due to the looseness 
of vasocentral cells. Hematoxylin/eosin stained. V, vasofibrous tissue. Scale bar, 100 
Pm. 
Fig. 11. 15 days post-injury. An increment of vasocentral cells in the vasofibrous tis- 
sue can be observed. Vasocentral cells fo rn  outstanding clusters in the interior of the 
vasofibrous fibers (arrows). Hematoxylin/eosin stabed. V, vasofibrous tissue. Scale bar, 
100 um. 
Fig. 12. Two months post-injury, when the pseudoblastema has been disintegrated, 
the vasofibrous tissue shows a normal aspect. Hematoxylin/eosin stained. V, vasofibrous 
tissue. Scale bar, 100 pm. 
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